Stock market update - not exam relevant
Summary
This article contains stock market price updates which are not relevant for exam preparation.
Full Article
Elara Capital sees GLP-1 drugs as a major tailwind for India’s pharma sector, potentially becoming first-line therapy for diabetes and obesity. The brokerage recommends buying five stocks, accumulating four others, and selling one amid shifting metabolic treatment trends globally ahead.
#business#economy#upsc#banking#ssc#rbi